Anaphylaxis is an
acute,
life-threatening,
multisystem syndrome
resulting from the
sudden release of
mediators derived
from mast cells and
basophils. Food
allergens are the
main triggers of
anaphylaxis,
accounting for
33%-56% of all cases
and up to 81% of
cases of anaphylaxis
in children. Human
anaphylaxis is
generally thought to
be mediated by IgE,
with mast cells and
basophils as key
players, although
alternative
mechanisms have been
proposed.
Neutrophils and
macrophages have
also been implicated
in anaphylactic
reactions, as have
IgG-dependent,
complement, and
contact system
activation. Not all
allergic reactions
are anaphylactic,
and the presence of
the so-called
accompanying factors
(cofactors or
augmenting factors)
may explain why some
conditions lead to
anaphylaxis, while
in other cases the
allergen elicits a
milder reaction or
is even tolerated.
In the presence of
these factors,
allergic reactions
may be induced at
lower doses of
allergen or become
more severe.
Cofactors are
reported to be
relevant in up to
30% of anaphylactic
episodes.
Nonsteroidal
anti-inflammatory
drugs and exercise
are the
best-documented
cofactors, although
estrogens,
angiotensin-converting
enzyme inhibitors,
β-blockers,
lipid-lowering
drugs, and alcohol
have also been
involved.
The mechanisms
underlying
anaphylaxis are
complex and involve
several interrelated
pathways. Some of
these pathways may
be key to the
development of
anaphylaxis, while
others may only
modulate the
severity of the
reaction. An
understanding of
predisposing and
augmenting factors
could lead to the
development of new
prophylactic and
therapeutic
approaches.
Key words:
Adenosine.
Anaphylaxis.
Cofactor. Exercise.
IgE. IgG. Mast cell.
NSAID. |